Subscribe

Arcoma AB (ARCOMA.ST)

SEK8.68 +0.40 (+4.83%)
SE STO Healthcare Medical - Devices
Address AnnavAegen 1 352 46
Växjö, SE
CEO Mattias Leire
Website arcoma.se
IPO 2014-11-14
ISIN SE0006219176

Explore sections of this company profile

Description

Arcoma AB is a global provider that designs, manufactures, and supplies cutting-edge radiology solutions. Their product line features advanced digital x-ray and radiography systems. These versatile systems are suitable for a wide array of radiographic applications and are utilized across various clinical environments, including general practice, musculoskeletal, thoracic, pediatric, and trauma/resuscitation units. The company distributes its products through a network of OEM partners. Arcoma AB was founded in 1990 and is headquartered in Växjö, Sweden.

Market Cap & Enterprise Value
Merger & Acquisition History

No mergers or acquisitions recorded for this company.

Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary Loading…
Indicator 1D1W2W3W1M
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
Averages
Trend
Price
Levels
Draw
SEK8.68 +0.40 (+4.83%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
8.6K
Beta
0.64
Float Shares
7.64M
Free Float %
53.4%
Price Performance
1D5D1M3M6M YTD1Y3Y5Y10YMax
-2.21% -12.04% +17.87% +4.00% +21.43% +22.78% -11.07% +17.09% -52.85% +80.41% -33.63%
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
vs.
Loading histogram data…

Revenue flow

Revenue by geography

Revenue by segment

From To

Revenue composition

From To

By product

By geography

Financial Statements

Income Statement

Balance Sheet

Cash Flow Statement

Key Metrics

Financial Ratios

Employees

Financial Growth (CAGR)

Market Data

Price Targets & DCF
Current price
8.68
DCF (Unlevered) 6.92 -20.3%
DCF (Levered) 14.34 +65.3%

DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.

Ratings Trend (MoM)
Rating 2026-05 Change
Strong Buy 0 0
Buy 0 0
Hold 0 0
Sell 0 0
Strong Sell 0 0
Quality scores
Altman Z-Score
4.97
Safe zone
Piotroski F-Score
5 / 9
Average
MOAT Score
3 / 10
No MOAT
Composite Rating
B
Overall Score
3 / 5
Medium
DCF Score
4 / 5
High
ROE Score
3 / 5
Medium
ROA Score
4 / 5
High
D/E Score
1 / 5
Low
P/E Score
1 / 5
Low
P/Book Score
4 / 5
High
Operational MOAT
✗ Below peers
  • ✗
    Revenue growth Medical - Devices: +11.2%
    -16.6% Q1'26: -10.7% (vs Q1'25)
  • ✗
    EPS growth Medical - Devices: +28.5%
    -58.8% Q1'26: -62.2% (vs Q1'25)
  • ✓
    FCF margin FCF growth · Medical - Devices: +30.9%
    +13.7% ★ Q1'26: -4.6% (vs Q1'25)
  • ✗
    EBIT margin Medical - Devices: +6.2%
    +6.6% ★ Q1'26: +4.6% (vs Q1'25)
  • ✓
    ROIC Medical - Devices: +3.3%
    +17.6% ★ Q1'26: +10.9% (vs Q1'25)
  • ✗
    Share dilution Medical - Devices: 0.0%
    +8.5% Q1'26: +8.5% (vs Q1'25)
  • ✓
    Debt / EBITDA Net debt/EBITDA · Medical - Devices: -0.35×
    0.00× ★ Q1'26: 0.00× (vs Q1'25)
Valuation Multiples From To
Price Forecast (3Y) From To
Model
Adjust
P/E
Theoretical Return — If Invested Today

* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.

DCF Interactive Model (UFCF)
Projection years:
Market assumptions
▶ WACC components (optional)
Ke (Cost of Equity) = Rf + β (0.59) × ERP
WACC = 100% × Ke + 0% × Kd (4.1%) × (1−t)

Modifying these values recalculates WACC automatically.

Business assumptions
—
Intrinsic value (base): 6.92 Current price: 8.68
Enterprise Value: — Equity Value: — Terminal Value: — TV as % of EV: —

Base values reflect the latest available data for this company and market conditions.

Consensus Estimates
Metric Dec 2019
actual 		Dec 2020
actual 		Dec 2021
actual 		Dec 2022
actual 		Dec 2023
actual 		Dec 2024
actual 		Dec 2025
actual 		Dec 2026
1 Rev. Ana.
1 EPS Ana. 		Dec 2027
1 Rev. Ana.
1 EPS Ana. 		Dec 2028
1 Rev. Ana.
1 EPS Ana.
Revenue
133.67M
est: 139.69M (-4.3%)
117.42M
est: 119.00M (-1.3%)
117.13M
est: 132.00M (-11.3%)
125.05M
est: 119.00M (+5.1%)
163.02M
est: 163.00M (+0.0%)
156.81M
est: 174.00M (-9.9%)
130.80M
est: 131.00M (-0.2%)
135.00M
135.00M – 135.00M
+3.1% YoY
141.00M
141.00M – 141.00M
+4.4% YoY
149.00M
149.00M – 149.00M
+5.7% YoY
EBITDA
10.80M
est: 5.60M (+92.7%)
4.97M
est: 4.77M (+4.2%)
-6.66M
est: 5.29M (-225.8%)
4.68M
est: 4.77M (-2.0%)
6.11M
est: 6.54M (-6.5%)
21.96M
est: 9.77M (+124.9%)
16.03M
est: 7.35M (+117.9%)
7.58M
7.58M – 7.58M
+3.1% YoY
7.91M
7.91M – 7.91M
+4.4% YoY
8.36M
8.36M – 8.36M
+5.7% YoY
EBIT
9.29M
est: 2.84M (+227.3%)
3.51M
est: 2.42M (+45.0%)
-8.15M
est: 2.68M (-403.9%)
3.02M
est: 2.42M (+25.0%)
4.52M
est: 3.31M (+36.5%)
14.03M
est: 4.81M (+191.8%)
8.68M
est: 3.62M (+139.9%)
3.73M
3.73M – 3.73M
+3.1% YoY
3.90M
3.90M – 3.90M
+4.4% YoY
4.12M
4.12M – 4.12M
+5.7% YoY
Net Income
6.61M
est: 9.45M (-30.1%)
1.37M
est: 9.63M (-85.8%)
-7.47M
est: 1.85M (-504.8%)
1.90M
est: 1.45M (+31.1%)
2.56M
est: 2.51M (+2.3%)
11.18M
est: 16.88M (-33.8%)
5.03M
est: 6.01M (-16.3%)
7.87M
7.87M – 7.87M
+31.0% YoY
10.73M
10.73M – 10.73M
+36.4% YoY
11.45M
11.45M – 11.45M
+6.7% YoY
SGA
17.11M
est: 28.74M (-40.5%)
18.89M
est: 24.48M (-22.8%)
21.06M
est: 27.16M (-22.4%)
17.19M
est: 24.48M (-29.8%)
45.25M
est: 33.53M (+34.9%)
42.79M
est: 30.20M (+41.7%)
—
est: 22.74M (-100.0%)
23.43M
23.43M – 23.43M
+3.1% YoY
24.47M
24.47M – 24.47M
+4.4% YoY
25.86M
25.86M – 25.86M
+5.7% YoY
EPS
0.52
est: 0.72 (-27.4%)
0.11
est: 0.73 (-84.9%)
-0.58
est: 0.14 (-514.3%)
0.15
est: 0.11 (+36.4%)
0.19
est: 0.19 (+0.0%)
0.85
est: 1.18 (-28.0%)
0.35
est: 0.42 (-16.7%)
0.55
0.55 – 0.55
+31.0% YoY
0.75
0.75 – 0.75
+36.4% YoY
0.80
0.80 – 0.80
+6.7% YoY
Historical Ratings (3M)
Date Rating Overall DCF ROE ROA D/E P/E P/B
2026-05-29 B 3/5 4/5 3/5 4/5 1/5 1/5 4/5
2026-05-28 B 3/5 4/5 3/5 4/5 1/5 1/5 4/5
2026-05-27 B 3/5 4/5 3/5 4/5 1/5 1/5 4/5
2026-05-26 B 3/5 4/5 3/5 4/5 1/5 1/5 4/5
2026-05-25 B 3/5 4/5 3/5 4/5 1/5 1/5 4/5
2026-05-22 B 3/5 4/5 3/5 4/5 1/5 1/5 4/5
2026-05-21 B 3/5 4/5 3/5 4/5 1/5 1/5 4/5
2026-05-20 B 3/5 4/5 3/5 4/5 1/5 1/5 4/5
2026-05-19 B+ 3/5 4/5 3/5 4/5 1/5 2/5 4/5
2026-05-18 B+ 3/5 4/5 3/5 4/5 1/5 2/5 4/5
2026-05-15 B+ 3/5 4/5 3/5 4/5 1/5 2/5 4/5
2026-05-13 B+ 3/5 4/5 3/5 4/5 1/5 2/5 4/5
2026-05-12 B+ 3/5 4/5 3/5 4/5 1/5 2/5 4/5
2026-05-11 B+ 3/5 4/5 3/5 4/5 1/5 2/5 4/5
2026-05-08 B+ 3/5 4/5 3/5 4/5 1/5 2/5 4/5
2026-05-07 B+ 3/5 4/5 3/5 4/5 1/5 2/5 4/5
2026-05-06 B+ 3/5 4/5 3/5 4/5 1/5 2/5 4/5
2026-05-05 B+ 3/5 4/5 3/5 4/5 1/5 2/5 4/5
2026-05-04 B+ 3/5 4/5 3/5 4/5 1/5 2/5 4/5
2026-04-29 B+ 3/5 4/5 3/5 4/5 1/5 2/5 4/5
2026-04-28 B+ 3/5 4/5 3/5 4/5 1/5 2/5 4/5
2026-04-27 B+ 3/5 4/5 3/5 4/5 1/5 2/5 4/5
2026-04-24 B+ 3/5 4/5 3/5 4/5 1/5 2/5 4/5
2026-04-22 A- 4/5 5/5 3/5 5/5 1/5 3/5 4/5
2026-04-21 A- 4/5 4/5 3/5 5/5 1/5 3/5 4/5
2026-04-17 A- 4/5 4/5 3/5 5/5 1/5 3/5 4/5
2026-04-16 A- 4/5 4/5 3/5 5/5 1/5 3/5 4/5

Owner Earnings

Owner's Earnings (history) From To
Owner alignment
Owner's Earnings TTM
15.04M
OE per share TTM
1.06
Owner's Yield
11.89%
Maintenance CapEx ratio
8.53%
Maint CapEx / Avg PPE
1.0%

Ownership Overview

Ownership breakdown

Ownership breakdown not available.

At a glance
Institutional holders
—
Total invested
—
Insider transactions (90d)
0
Beneficial owners (>5%)
0
Beneficial owners (>5%)

No beneficial ownership filings recorded.

Institutional Activity (13F)

Institutional ownership trend

Institutional history not available.

Top institutional holders

Top holders not available.

ETF Ownership

Top ETFs holding this stock

This company is not held by any ETF in our universe.

Insider Activity

Insider Activity — Latest Quarter

No insider activity available.

Insider buys vs sells (history)

Insider history not available.

Recent insider transactions

No recent insider transactions.

Executive team

Top executives
EBIT / Employee
280.1K
Shares Outstanding
14.31M

Executive compensation

Executive compensation (annual)

Executive compensation not available.

CEO compensation breakdown

No CEO compensation history available.

Proxy statements

Proxy statements (DEF 14A)

No proxy statements available for this company yet.

Recent SEC filings

Recent SEC filings

No SEC filings available for this company yet.

Executive team

NameTitleCompensationGender
Andre Malmberg Chief Operating Officer — male
Daniel Warawasowski Global Sales Director — —
Johan Dahlberg Chief Financial Officer — male
Mattias Leire Chief Executive Officer — male
ESG Score History

No data available for this company.

Senate Trading Activity

No Senate trading activity found for this company.

House Trading Activity

No House trading activity found for this company.

Market share among peers
Peer comparison — filtered group (TTM)
Your opinion

Share your view on this stock and instantly see how the community has voted over the last 6 months.

These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

Dividend history

Earnings history

Earnings reports

Stock splits

Related companies

Largest companies in Medical - Devices